fda shortage glp-1 Compounded GLP-1s: Why doctors worry and the is cracking down FDA says shortage of GLP-1

Who Might Benefit From B12/MIC Injections

Recently, we demonstrated that the cyclolignan PPP inhibited phosphorylation of IGF-1R without interfering with insulin receptor activity (Girnita et al, 2004), as well as it reduced phosphorylated Akt, caused apoptosis and induced tumour regression in xenografted mice

Any references to insulin-like growth factor, growth-related pathways, or metabolic endpoints are provided for scientific context only

JAMA 327 , 534545 (2022) M.J

Like GLP1s, combo GLP-1/GIP medication was found to be an effective weight loss medication and therefore it was studied through clinical trials and was found it to be a safe and effective tool for weight loss

Eur J Cancer 1996